Patient Characteristics, Treatment Patterns, and Healthcare Resource Utilization of Metastatic Melanoma Patients

Clinical trial NCT06369428 · COMPLETED

Trial details

NCT number: NCT06369428
Sponsor: Novartis
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Melanoma

Start date: 2021-06-23
Primary completion: 2023-04-13
Enrollment: 1795

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.